Key player · Company profile

BioMarin

Named as a key player in 165 of our reports, across 33 regions and countries.

165Reports naming them
1Categories
33Regions & countries
See reportsGrowth in full reports

Where they show up

Pharmaceuticals165

Geographies

BioMarin's markets

Markets where BioMarin is a key player, with the world market size
Market	Category	World size	Growth
AAV Gene Therapy	Pharmaceuticals	In full report	In full report
Enzyme Replacement Therapy	Pharmaceuticals	In full report	In full report
Gene Therapy for Hemophilia	Pharmaceuticals	In full report	In full report
Lysosomal Storage Disease Treatment	Pharmaceuticals	In full report	In full report
Phenylketonuria Treatment	Pharmaceuticals	In full report	In full report

Companies they compete with most

Named as key players in the same markets as BioMarin (number of shared markets).

Amicus Therapeutics2 shared markets Chiesi2 shared markets CSL Behring2 shared markets

Sanofi2 shared markets

Takeda Pharmaceutical Company Ltd2 shared markets

Ajinomoto1 shared market Homology Medicines1 shared market

Nestle1 shared market

Recent reports naming BioMarin

Search all reports for BioMarin All companies